发明授权
- 专利标题： Pyrimidineamines as angiogenesis modulators
- 专利标题（中）： 嘧啶胺作为血管生成调节剂
-
申请号： US11383229申请日： 2006-05-15
-
公开(公告)号： US07262203B2公开(公告)日： 2007-08-28
- 发明人: Amogh Boloor , Mui Cheung , Ronda Davis , Philip Anthony Harris , Kevin Hinkle , Robert Anthony Mook, Jr. , Jeffery Alan Stafford , James Marvin Veal
- 申请人： Amogh Boloor , Mui Cheung , Ronda Davis , Philip Anthony Harris , Kevin Hinkle , Robert Anthony Mook, Jr. , Jeffery Alan Stafford , James Marvin Veal
- 申请人地址： US PA Philadelphia
- 专利权人： SmithKline Beecham Corporation
- 当前专利权人： SmithKline Beecham Corporation
- 当前专利权人地址： US PA Philadelphia
- 代理商 Jennifer L. Fox
- 主分类号： C07D239/48
- IPC分类号： C07D239/48 ; C07D403/04 ; A61K31/506 ; A61P27/02
摘要：
Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
公开/授权文献
- US20070015756A1 Chemical compounds 公开/授权日：2007-01-18
信息查询
